Search research articles
Contact Us
Filters
Showing results (411-420 of 669) with videos related to
Page
of 67
Sort By:
Journal of Molecular Liquids
|
November 28, 2025
Bypassing P-glycoprotein mediated efflux of afatinib by cyclodextrin complexation - Evaluation of intestinal absorption and anti-cancer activity
Vineela Parvathaneni, Rasha S Elbatanony, Snehal K Shukla, et al.
Cancer Research
|
July 23, 2003
Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport
Zhe-Sheng Chen, Robert W Robey, Martin G Belinsky, et al.
Signal Transduction and Targeted Therapy
|
October 8, 2022
Signaling pathways and therapeutic interventions in gastric cancer
Zi-Ning Lei, Qiu-Xu Teng, Qin Tian, et al.
Cancer Biology & Therapy
|
December 2, 2005
Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo
Zhi Shi, Yong-ju Liang, Zhe-sheng Chen, et al.
Protein & Cell
|
November 19, 2020
Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction
Wenyu Fu, Yujianan Chen, Kaidi Wang, et al.
BMC Surgery
|
May 29, 2013
Overexpression of cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma
You-Fang Chen, Gang Ma, Xun Cao, et al.
Cancers
|
February 16, 2020
ABCG2 Overexpression Contributes to Pevonedistat Resistance
Rishil J Kathawala, Claudia M Espitia, Trace M Jones, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
July 4, 2021
The role of endolysosomal trafficking in anticancer drug resistance
Noor A Hussein, Saloni Malla, Mariah A Pasternak, et al.
Cancer Letters
|
October 14, 2018
Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells
Ning Ji, Yuqi Yang, Chao-Yun Cai, et al.
Frontiers in Pharmacology
|
March 7, 2022
Abiraterone, Orteronel, Enzalutamide and Docetaxel: Sequential or Combined Therapy?
Ming-Kun Chen, Zhi-Jian Liang, Dao-Sheng Luo, et al.
Page
of 67
Search research articles
Search
Showing results (411-420 of 669) with videos related to
Sort By:
Page
of 67
Journal of Molecular Liquids
|
November 28, 2025
Bypassing P-glycoprotein mediated efflux of afatinib by cyclodextrin complexation - Evaluation of intestinal absorption and anti-cancer activity
Vineela Parvathaneni, Rasha S Elbatanony, Snehal K Shukla, et al.
Cancer Research
|
July 23, 2003
Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport
Zhe-Sheng Chen, Robert W Robey, Martin G Belinsky, et al.
Signal Transduction and Targeted Therapy
|
October 8, 2022
Signaling pathways and therapeutic interventions in gastric cancer
Zi-Ning Lei, Qiu-Xu Teng, Qin Tian, et al.
Cancer Biology & Therapy
|
December 2, 2005
Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo
Zhi Shi, Yong-ju Liang, Zhe-sheng Chen, et al.
Protein & Cell
|
November 19, 2020
Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction
Wenyu Fu, Yujianan Chen, Kaidi Wang, et al.
BMC Surgery
|
May 29, 2013
Overexpression of cystatin SN positively affects survival of patients with surgically resected esophageal squamous cell carcinoma
You-Fang Chen, Gang Ma, Xun Cao, et al.
Cancers
|
February 16, 2020
ABCG2 Overexpression Contributes to Pevonedistat Resistance
Rishil J Kathawala, Claudia M Espitia, Trace M Jones, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
July 4, 2021
The role of endolysosomal trafficking in anticancer drug resistance
Noor A Hussein, Saloni Malla, Mariah A Pasternak, et al.
Cancer Letters
|
October 14, 2018
Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells
Ning Ji, Yuqi Yang, Chao-Yun Cai, et al.
Frontiers in Pharmacology
|
March 7, 2022
Abiraterone, Orteronel, Enzalutamide and Docetaxel: Sequential or Combined Therapy?
Ming-Kun Chen, Zhi-Jian Liang, Dao-Sheng Luo, et al.
Page
of 67